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Abstract
Background: People with HIV are living longer with the health-related consequences of HIV, multi-morbidity, and
aging. Exercise is a key strategy that may improve or sustain health for people living with HIV. Our aim was to
examine the safety and effectiveness of aerobic exercise interventions on immunological, virological,
cardiorespiratory, strength, weight, body composition, and psychological outcomes in adults living with HIV.
Methods: We conducted a systematic review using the Cochrane Collaboration protocol. We searched databases
up to April 2013. We included randomized controlled trials comparing aerobic exercise with no exercise or another
intervention performed at least three times per week for at least four weeks among adults living with HIV. Two
reviewers independently determined study eligibility. Data were extracted from studies that met inclusion criteria
using standardized forms. We assessed risk of bias using the Cochrane Collaboration’s tool for assessing risk of bias.
Outcomes were analyzed as continuous and meta-analyses conducted using random effects models with Review
Manager (RevMan) computer software.
Results: Twenty-four studies met inclusion criteria (n = 936 participants at study completion); the majority of
participants were men (73 %) and the majority were taking antiretroviral therapy (19/24 included studies). The
exercise intervention included aerobic exercise alone (11 studies) or a combination of aerobic and resistive exercise
(13 studies) ranging from 5 to 52 weeks. Fifty-eight meta-analyses were performed. Main results indicated
statistically significant improvements in selected outcomes of cardiorespiratory status (maximum oxygen
consumption, exercise time), strength (chest press, knee flexion), body composition (lean body mass, percent body
fat, leg muscle area), depression symptoms, and quality of life (SF-36 questionnaire) among exercisers compared
with non-exercisers. No significant differences in change in CD4 count and viral load were found.
Conclusions: Performing aerobic exercise or a combination of aerobic and resistive exercise at least three times per
week for at least five weeks is safe and can lead to improvements in cardiorespiratory fitness, strength, body
composition and quality of life for adults with HIV. Aerobic exercise is safe and beneficial for adults living with HIV
who are medically stable.
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Background
Access to combination antiretroviral therapy has trans-
formed HIV into a chronic illness whereby many individ-
uals are living longer and aging with the health-related
consequences of HIV, adverse effects of treatment and
multi-morbidity [1–4]. These consequences may be known
as “disability” including symptoms and impairments (prob-
lems with body function or structure, such as pain or
fatigue), activity limitations (difficulties in executing day-
to-day activities, such as inability to walk), challenges to so-
cial inclusion (problems in life situations, such as inability
to work, personal relationships), and uncertainty about fu-
ture health (worrying about the future) [5, 6].
Exercise is a strategy employed by people living with
HIV and by rehabilitation professionals to address dis-
ability and improve or sustain the health of people living
with HIV [7]. Exercise has been shown to improve
strength, cardiovascular function, and psychological sta-
tus in general populations [8, 9]. Similar benefits of aer-
obic exercise were documented in earlier versions of this
systematic review among adults living with HIV [10, 11].
However, knowledge about the benefits and risks of ex-
ercise, and optimal parameters for exercise for adults liv-
ing with HIV is still emerging. If the risks and benefits
of exercise for people living with HIV are better under-
stood, appropriate exercise may be undertaken by people
in this population and appropriate exercise prescription
may be practiced by healthcare providers. Effective and
safe exercise may enhance the effectiveness of HIV man-
agement, thus improving overall health outcomes for
adults living with HIV.
Our aim was to examine the safety and effectiveness of
aerobic exercise interventions on immunological, viro-
logical, cardiorespiratory, strength, weight, body com-
position, and psychological outcomes in adults living
with HIV.
Methods
We conducted a systematic review using the Cochrane
Collaboration protocol [12].
Inclusion criteria
We included randomized controlled trials (RCTs) com-
paring aerobic exercise (or combined aerobic and resist-
ance exercise) with no aerobic exercise or another
exercise or treatment modality performed at least three
times per week for at least four weeks [13]. We included
studies of adults (18 years of age and older) living with
HIV at all stages of infection with or without comorbidi-
ties. We defined aerobic exercise as a regimen contain-
ing aerobic interventions performed at least three times
per week for at least four weeks. Aerobic interventions
included but were not limited to walking, jogging,
cycling, rowing, stair stepping, and swimming. Interven-
tions may or may not have been supervised [13].
Outcomes
We assessed immunological (CD4 count, cells/mm3) and
virological (viral load, log10 copies) outcomes. Cardiorespi-
ratory measures included but were not limited to maximal
oxygen consumption (VO2max), exercise time, oxygen
pulse, maximum heart rate, maximum tidal volume, minute
ventilation, lactic acid threshold (LAT), maximum work
rate, and rate of perceived exertion. Strength measures in-
cluded amount of weight able to resist in kilograms (1-repe-
tition maximum) for major muscle groups. Weight and
body composition measures included any outcome that
contributes to the direct or indirect measurement of
muscle, fat, bone or other tissues of the body. These in-
cluded but were not limited to body weight, body mass
index (BMI), lean body mass, girth, percent body fat, cross-
sectional muscle area, and waist and hip circumference.
Psychological measures included general measures of psy-
chological status and health-related quality of life.
Search strategy
In the update of this systematic review, we searched data-
bases from 2009 to April 2013 including Medline,
Cochrane Central Register of Controlled Trials, Cochrane
Database of Systematic Reviews, Database of Abstracts of
Reviews of Effects, PsycINFO, CINAHL, EMBASE, Web
of Science: Science Citation Index, SPORTdiscus, Virology
and AIDS Abstracts and LILACS. We also searched clini-
caltrials.gov and reference lists from pertinent articles. All
languages were included. See Additional file 1 for the de-
tailed MEDLINE search strategy which we modified as
needed for use with other databases.
Selection of included studies
All abstracts retrieved from the search were reviewed in-
dependently by two reviewers (KKO and AMT) who ap-
plied the following four inclusion criteria to determine if
the abstract warranted further investigation: a) Did the
study include human participants who were HIV posi-
tive? b) Did the study include adults 18 years of age or
older? c) Did the study include an aerobic exercise inter-
vention performed at least three times/week, at least
20 min per session for at least four weeks? d) Was there
a randomized controlled comparison group?
When the review based on the abstract alone indicated
that one or both raters believed the study met eligibility cri-
teria (i.e., if reviewers answered “yes” or “unsure” to the four
questions) then full versions of the article were independ-
ently reviewed by the two reviewers to determine article in-
clusion. In instances where there was a lack of agreement
by the two reviewers, a third reviewer was asked to review
the full article to determine final inclusion.
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Data extraction
Data were extracted onto standard data extraction forms
independently by at least two reviewers (KKO and AMT
and/or SAN). Data extracted included the study citation,
study objectives, study design, length of study, time at
which participants were assessed, inclusion and exclu-
sion criteria for participants, characteristics of included
participants (i.e., age, gender, stage of disease, comorbid-
ity), description of intervention(s) (i.e., frequency, inten-
sity, duration, type, level of supervision, location of
intervention), types of outcome variables assessed and
their values at baseline and study completion, and num-
ber of participants at baseline and study completion (in-
cluding number of withdrawals). For the purposes of
this review, constant exercise was defined as exercise at
a constant intensity for a period of time. Interval exer-
cise was defined as exercise conducted at a varied inten-
sity for a total period of time. The reviewers met to
achieve consensus regarding any difference in data inter-
pretation or extraction from included studies that arose
during the review process. In the case of missing data,
authors were contacted in an attempt to obtain further
information.
Two authors assessed the risk of bias in the included
studies using the Cochrane Collaboration’s tool for
assessing risk of bias [14]. Potential biases in studies
may have included selection bias (random sequence gen-
eration and allocation concealment which may result in
systematic differences in the comparison groups), per-
formance bias (blinding of participants and personnel
which could lead to systematic differences in the care
provided apart from the intervention being evaluated),
detection bias (blinding of outcome assessment that may
result in systematic differences in outcome assessment),
attrition bias (incomplete outcome data), and reporting
bias (selective reporting of outcomes) [14].
We assessed the overall quality of evidence using the
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) method [15]. We rated the
quality of evidence for each outcome based on categories
of very low, low, moderate and high [16]. We down-
graded the evidence from high quality by one level for
each of the following: attrition bias (where withdrawal
rates were >15 %), performance bias (when partici-
pants were not blinded to the intervention), detection
bias (when assessors of outcomes were not blinded to
group allocation), publication bias (when publication
bias was suspected), and inconsistency (when moder-
ate I2 > 40 % or substantial I2 > 75 % heterogeneity
exists) [17].
We produced a summary of findings (SoF) table for
the main comparison of exercise versus no exercise with
the following seven outcomes: immunological (CD4
count) and virological (viral load); cardiorespiratory
(VO2max); strength (upper and lower body), weight
(body weight); body composition (body mass index); and
quality of life (SF-36 sub-scale scores). The SoF table
was developed to illustrate the confidence in the effect
estimates (quality of evidence) and magnitude of effect
for seven key outcomes [18].
Analysis
Outcomes were analysed as continuous and dichotomous
outcomes whenever possible. Meta-analyses were per-
formed using the random-effects model for outcomes using
Review Manager (RevMan) computer software whenever
there were sufficient data available in the studies, when
similar or comparable outcome measures were used, and
when participant comparison groups were similar [19].
For continuous outcomes, the weighted mean difference
(WMD) and 95 % confidence intervals for the means were
calculated whenever possible. For dichotomous outcomes,
the odds ratio, absolute difference in odds, relative risk
(RR), risk difference (RD), and the number needed to treat
(NNT) and 95 % confidence intervals were calculated
whenever possible. A p value of less than 0.05 indicated
statistical significance for overall effect.
Subgroup analyses were performed whenever possible
to estimate whether aerobic exercise interventions were
associated with differences among groups using identi-
fied outcome measures.
We considered 50 cells/mm3 to indicate a clinically im-
portant change in CD4 count, 5 % to indicate a clinically
important change in CD4 percentage, and 0.5 log10 copies
to indicate a clinically important change in viral load. For
cardiorespiratory outcomes, we considered 2 mL/kg/min
to indicate a clinically important change in VO2max, 10
beats per minute to indicate a clinically important change
in heart rate maximum (HRmax), and 5 min to indicate a
clinically important change in exercise time. For strength
outcomes we considered 5 kg to indicate a clinically im-
portant change in strength for lower extremities, 2 kg to
indicate a clinically important change in strength for
upper extremities. For weight and body composition out-
comes, we considered 3 kg to indicate a clinically import-
ant change in body weight (which equals approximately
5 % of the average baseline body weight of participants),
5 cm to indicate a clinically important change in girth
(waist and hip circumference), 3 cm to indicate a clinically
important change in waist-to-hip ratio, 5 kg/cm2 to indi-
cate a clinically important change in body mass index,
5 kg to indicate a clinically important change in fat mass,
5 % to indicate a clinically important change in percent
body fat, and 5 cm2 to indicate a clinically important
change in leg muscle area. For psychological outcomes,
we considered 10 points to indicate a clinically important
change in the sub scales of the SF-36 quality of life ques-
tionnaire; and 5.6 to indicate a clinically important change
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in the sub scales of the Profile of Mood States (POMS)
scale [20]. While no established minimal clinically import-
ant difference (MCID) exists for the SF-36 questionnaire
specifically with people living with HIV, we drew from
other literature with clinically important differences for
the SF-36 with other chronic conditions which demon-
strates a small change is approximately 10 points [21, 22].
No other established MCID values exist for the other out-
comes. Authors based the a priori estimates based on a
combination of clinical experience and interpretations in
the individual included studies.
We considered a p value of less than 0.1 as statistical
significance for heterogeneity between studies [23]. We
considered I2 ≤ 40 as low heterogeneity, I2 > 40–75 %
moderate and I2 > 75 % substantial heterogeneity [17]. In
instances of lack of statistical significance for an overall ef-
fect, confidence intervals were assessed for potential
trends that may suggest movement towards an increase or
decrease in overall effect. In instances of statistical signifi-
cance for heterogeneity, we performed sensitivity analyses
and explained potential reasons for heterogeneity.
Results
Fourteen studies were included in the previous system-
atic review [10]. In this update, we retrieved a total of
529 citations, of which 58 were judged to merit scrutiny
of the full article. Of the 58 studies reviewed, 11 met the
inclusion criteria, one of which was a duplicate study
[24] resulting in a total of 10 studies included in this
fourth update [25–34] (Fig. 1-PRISMA Flow Diagram).
Hence, a total of 24 studies (14 from the earlier review
and 10 from the update) were included in this systematic
review (See Table 1-Characteristics of Included Studies).
An additional seven articles were identified as duplicate
publications of studies included in the review: Kaushik
[24] and Fitch [31] (in this update); and; LaPerriere [35]
and LaPerriere [36]; Lox [37] and Lox [38]; Neidig [39]
and Smith [40]; Fairfield [41] and Grinspoon [42];
Driscoll [43] and Driscoll [44]; and Mutimura [45] and
Mutimura [46] (in the earlier review). In these instances,
we extracted outcomes from all available sources but refer
to the initial citation and/or the citation that included our


































Full-text articles assessed for 
eligibility
(n = 58)
Full-text articles excluded, 
with reasons 
(n = 49)
Studies included in systematic 
review update
(n = 9)
Studies included in final systematic review update 
(n = 10)
Studies included in earlier versions of review (n=14)




reference check of 
another systematic review 
(n = 1)
Fig. 1 PRISMA Flow Diagram of Included Studies in Aerobic Exercise and HIV Systematic Review Update
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Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24)





























76 39 % 100 % 70 6/76
(8 %)
EXERCISE (PRE +AER) +
CONTROLLED DIET
INTERVENTION GROUP:
Participants placed on a
systematic and controlled
diet and physical exerciser
(aerobic activity of
moderate intensity).
Aerobic: walking on a
treadmill for 40 min, run
30 min and stair climb
for 15 min. Anaerobic
components included:
40 min of PRE weight
training in arms and
legs; 10 cycles 3 repetitions.
PRE: 2 kg for women and 5 kg






























40 min total: 5 min
stretching, 5 min warm-up
on machine, 20 min
constant aerobic exercise
at 75–85 % HRmax










































Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)
























3) DIET + EXERCISE +
niacin only plus 1
placebo versus
4) DIET + EXERCISE +
fenofibrate only plus 1
placebo versus
5) USUAL CARE (with 2
placebos). [5 groups]
bNote for this systematic
review we compared
Group 1 (exercise + diet)









in an exercise program
following ACSM guidelines.
Aerobic: Participants began
with 10 min stretching and
5 min warm-up; followed
by 20–25 min of aerobic
exercises (stationary bike
and ergometer) at intensity
of 70–85 % maximal heart
rate or 60–80 % HR reserve,








45–50 min; three sets
of 8–12 repetitions
with a rest break of
1–3 min between each
set; followed by
5–10 min cool down.
Intensity: 60–80 % 1
repetition maximum
(1RM) of leg and bench
press. After a given





























Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)

















heart healthy diet, kept
a 7 day food record and
received feedback on
their caloric intake
during a single baseline
visit. Participants received






























5 min warm-up on




aerobic and PRE exercise
according to ACSM
guidelines followed
by a cool down period.
PRE: concentric and
eccentric phases of
6 selected upper and
lower body muscle
groups; Week 1: 3 sets
of 10 reps for each
muscle group at 60 %
1-RM, 3–5 s between
reps rest, 2 min rest
between sets, 4 min
rest between muscle
groups; week 3–16:
4 sets of 8 reps for
each muscle group
at 70 % 1-RM (Week
2–3), and 80 % 1-RM
(week 4–16), 2–3 s
between reps rest,
1 min rest between





















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)













































Aerobic: 20 min aerobic
exercise on stationary cycle
at 60 % HRmax (week 1–2)
and progressing to 30
min at 75 % HRmax (week
3–12) according to ACSM
guidelines, 5 min warm-up
on stationary bike, standard
flexibility routine, followed
by resistance training.
PRE: of 3 sets of 10 repetitions
for every muscle group,
resting 2–3 s between
repetitions, 2 min between
sets, and 4 min between
muscle group. Week
1: initial intensity of PRE
was 60 % 1-RM; week
2–4 intensity increased
to 70 % 1-RM; week
4–12 intensity of 80 %
1-RM. 1-RM was measured
every other week and
load adjusted to maintain
relative intensity at 80 %
1-RM.
METFORMIN ONLY
GROUP: 500 mg of
metformin twice
per day, with a dose
increase to 850 mg





















27 NR 100 % 27 0/27
(0 %)
INTERVENTION GROUP
(Aerobic + PRE Exercise):





















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)


















30 min at moderate
intensity.
PRE: 3 sets of 12 reps
of 5 exercises at 60–80 %
12-RM. 1st week - 3 sets
of 21 repetitions at 60 %
12 repetition maximum
(12 RM) for all exercises.
remaining weeks, the
workload was 80 % of
12-RM for the following




rest intervals of 2–3 min
between sets and exercises.
Flexibility: 10 min - 2 sets
of 30 s at maximal range
of motion of 8 exercises





































exercise 3 times per week
(supervised) with dietary
counselling once per week.
Aerobic: Warm up
was 5 min of stationary
bike at 50 % maximum
heart rate (220 minus age).
Aerobic training was
performed using a
stationary cycle - each
participant exercised
for 20 min at 60 % their
maximal HR (220-age)
for the first 2 weeks
followed by 30 min at
75 % their maximal
heart rate for the
duration of the study.
[20 min total]
PRE: The aerobic training
50 min total
(20 min aerobic;

















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)


























3 sets of 10 reps for
each exercise, their
effort was increased
over 6 months from
60 to 80 % of their
1RM. For those unable












first 18 weeks with
review and reinforcement




Exercise (or LSM) as
per above plus 500 mg
of metformin twice a
day with a dose increase






groups: 1) PRE +
AEROBIC versus 2)





















Aerobic: 20 min aerobic
exercise on stationary























Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)



































follows: weeks 1 and 2,
2 sets at 8 repetitions
per set, 60 % 1-RM;
weeks 3 to 6, 2 sets,
8 repetitions per set,
70 % 1-RM; weeks




















Stationary bike 45 min
total @ 80 % HRmax for
3 min, then @ 60–79 %
























of 8 different programs
with 35 min of interval
training. 5 min warm-up.
Intensity varied from
50–100 % VO2max.
The first 8 weeks
the mean intensity
was targeted at 65 %
VO2max and the last
8 weeks were targeted
























Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)



















consisted of 8 exercises
(leg curl, pull down,
seated leg press, chest





45–60 min. The # of
repetitions and sets
changed every week.




































GROUP (PRE): 45 min
total. Isotonic resistance
to major muscle groups
in legs, arms and upper
body. Resistance was
initiated at 60 % of an
individual’s 1-RM and
increased by either 5
or 10 lb at a time after
successful performing


































GROUP: High intensity exercise:
24 min total @75–85 %




40 min total @50–60 %

















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)






































20 min of cycling
on a cycle ergometer,
followed by 20 min
of walking on a
treadmill. This was
followed by a home
program of exercises
and participants were
shown how to monitor
their respiratory, heart,
and blood pressure at
home. Home protocol =
10 min each of brisk
walking, squatting with
hands on the hips and
jogging on the spot
three times per week
(total of 30 min).
Intensity of Aerobic
Exercise: Minimal
resistance for 2 sessions
of 10 min of cycling
and 5 min of rest. This
was followed by 2
sessions of 10 min
of treadmill walking
on a motorized
treadmill with 5 min
of rest (Modified Bruce
protocol was used).
Moderate Intensity
included 50–70 % of
age-predicted maximum
heart rate (220 age in
years) with heart rate
maximum set within
10 beats of this
percentage predicted



































Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)





















20 min of minimal
heat therapy to their
thigh muscles of each




at home for 30 min,



















at a fitness club in
Kigali, Rwanda.
Aerobic Exercise: ‘proper
warm up’, stretching, and
15 min of brisk walking,











jogging and running with
the goal of achieving at
least 45 % maximum heart
rate (Weeks 1–3), 60 %
maximum heart rate













































Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)






















in 54 % of
participants)
GROUP: Participants
engaged in 1 h supervised
gym class 3 times per
week plus monthly dietary
counseling by a nutrition
specialist. Intensity of



















how to include them
in their daily routine.
They were stimulated
to perform activities like
running, biking or
walking for 1 h at














0 % 10 % 19 8/27 (30 %) EXERCISE (AEROBIC + PRE)
INTERVENTION GROUP:
3 weekly sessions of
90-min duration each.
Each session started





pedalling at very light
workloads and
stretching exercises






















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)




























the end of each set
of resistance exercise.
In month 1, participants
performed two and one
set of exercises for large
and small muscle groups
and all sets were performed
at a resistance that allowed
12–15 repetitions. Then, the
resistance used was
individually adjusted to
allow the completion of
8–10 repetitions for three
sets of the large muscle group
exercises and two sets of
the small muscle group
exercises. The resistance
used for each exercise was
increased by 5–10 % when
the participant could perform
the prescribed maximal
repetitions per set. After
an increase in resistance,
the repetitions per set
typically decreased to
the low end of the
prescribed repetition
range (12 or 8
repetitions). Abdominal
crunches and low back
extensions were
performed in two
sets of 15–20 repetitions
at the start of the program














Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)



















Aerobic Exercise: At the
beginning of the program,
aerobic training consisted
of pedalling on a cycle
ergometer for 20 min at
70 % of the age-predicted
maximum heart rate. The
duration and intensity of
the sessions were gradually
increased during the
4-month period so that
participants completed
45 min of continuous
pedalling at 80 % of
HRmax by the end of
the training program.




to divide the first sessions
into shorter time intervals







level < 2; walking for a
total of 30–60 min
three days per week)
and performing no
strenuous exercise






















Stationary bike 45 min
total @ 70–80%HR max x
3 min then 2 min “off”






















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)


































bike 60 min total
@60–80 % HRreserve x
20 min (2 min
warm-up and 3 min
cool down at low
intensity.) Stretching x






times per week for
12 weeks.











60 13 % 23 % 49 11/60
(18 %)
INTERVENTION GROUP:
Minimum of 30 min
constant aerobic exercise






































@ 50 % of difference
between Lactic Acid
Threshold (LAT) and VO2




















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)





























HRmax x 30 min
(5 min @ target
intensity, 1 min
recovery.) (15 min




@75–85 % HRmax x
30 min (5 min @ target
intensity, 1 min recovery)












exercise + low lipid
diet versus low lipid







33 % 100 % 30 12/42
(28 %)
INTERVENTION GROUP
(Exercise + Low Lipid
Diet): Constant aerobic
exercise consisting of
running for 30 min at
70–85 % HRmax, with
15 min stretching
exercises to warm-up
and 15 min to cool-
down (total of 1 h).
NON-EXERCISING
CONTROL GROUP
(Low Lipid DIet Only):
45 min soft stretching
and relaxation routines,
three times a week also
supervised by one of the
investigators, without


















Aerobic Exercise: Week 1
and 2: These 2 weeks





















Table 1 Characteristics of Included Studies in the Aerobic Exercise and HIV Systematic Review (n = 24) (Continued)



















This consisted of 3
endurance sessions,
5 min warm up and
cool down periods





intensity of 60 %
maximal heart rate.
Progression of Aerobic
Intensity: After the initial
60 % of aerobic training
intensity and 60 % of
1RM resistance training
intensity during the phase
in period, intensity was
gradually increased to
65 % of HRmax and 65 %
of 1RM in Step 1, to 70 %
in Step 2 and to 75 % in
Step 3.
PRE: All endurance sessions
were followed immediately
by core consisting of 8 two
to three sets of 15 to 20
repetitions, and one set
of 12 repetitions for ten
exercises performed on
stacked weight machines.
The initial level for the
resistance exercises was
set at 60 % of one
repetition maximum
(1RM). Progression of PRE
Intensity: In addition, Step
1 consisted of high
repetitions (12), followed
by lower repetitions in
Step 2 and Step 3 (10
and 8 repetitions,
respectively). Furthermore,
similar to the phase-in
period, other phases
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asked not to participate





























50–85 % HR reserve
(moderate to high
intensity). During
exercise, HR and time
at the target
HR were monitored.
Signaled an alarm if
target HR was not
maintained. HR and
time data were stored
to verify adherence and











the 1st 3–4 exercise
sessions on each of the
machines. Initially PRE
consisted of 1–2 sets
of each exercise while
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failure after 8 repetitions.
The trainer monitored the
participant’s exercise
response daily and when
the participant comfortably
lifted the weight for 12
reps on any exercise,
the weight (intensity)
was increased by an
amount 10 % that
caused the muscle
group to fatigue/fail













AER aerobic exercise, PRE progressive resistive exercise, NR not reported, cART combination antiretroviral therapy, ACSM American College of Sports Medicine, LAT lactic acid threshold
astudy included in this recent update of the systematic review
bFor the purpose of this review, only the aerobic and control groups were included in meta-analyses















All 24 included studies were randomized controlled tri-
als. Fifteen studies included a non-exercising control
group [26, 27, 29, 31, 32, 36, 38, 40, 42, 46–51]. Eight
studies included co-intervention groups, comparing ex-
ercise plus diet or nutritional counselling versus diet or
nutritional counselling only (Terry [52] low lipid diet;
Ogalha [28] nutritional counselling; Balasubramanyam
[33] low lipid diet plus exercise recommendation; Agos-
tini [34] standard diet); exercise plus metformin versus
metformin only (Driscoll [44]; Fitch [31]) exercise plus
testosterone enanthate versus testosterone only (Grin-
spoon [42]) and exercise plus pioglitazone versus pioglit-
azone only (Yarasheski [25]). One study included a non-
exercising counselling group (exercise vs. counselling
group) [47]; two studies included a progressive resistive
exercise (PRE) group compared with an aerobic exercise
group [30, 38]; and two studies had comparison groups
that compared heavy with moderate exercise [53, 54]. In
18 studies exercise was described as supervised [25–28,
30–33, 38, 40, 42, 44, 46–48, 50–52] and in the
remaining four studies, the level of supervision was not
stated. Two of the studies involved a supervised home-
based exercise intervention [50, 51] and one study in-
volved a combination of exercise at a rehabilitation cen-
ter (supervised once per week) and home-based exercise
(un-supervised three times per week) [29]. Ten studies
involved exercise at a supervised facility such as a hos-
pital [25, 44], medical or rehabilitation center [29, 40],
exercise facility, fitness or wellness centre [26, 28, 30,
46], gymnasium [33], or prison [27]; whereas the loca-
tion of exercise was not specified in the remaining 12
studies.
Characteristics of participants
A total of 1242 participants were included in the review
(number of participants in included studies at baseline).
Participants included adults living with HIV at various
stages of HIV infection, with CD4 counts ranging from
<100 cells/mm3 to greater than 1000 cells/mm3. Studies
included both men and women, with women comprising
approximately 22 % of the total number of participants
at study completion. The mean age of the participants in
the included studies ranged from 30 to 49 years (inclu-
sion criteria ranged from 18 to 65 years of age).
Four studies (17 %) were published prior to introduc-
tion of combination antiretroviral therapy (prior to
1996) [36, 38, 47, 53] followed by six (25 %) between
1998 and 2002 [40, 42, 48–50, 54], six (25 %) between
2004 and 2008 [27, 30, 44, 46, 51, 52] and eight (33 %)
between 2009 and 2013 [25, 26, 28, 29, 31–34]. The ma-
jority of participants in 14 studies were taking combin-
ation antiretroviral therapy including 72 % [42]; 82 %
[51] and 100 % on highly active antiretroviral therapy
[25, 26, 28–34, 44, 46, 52]. Smith [40] reported 23 % of
participants were taking protease inhibitors and all other
participants were on some form of antiretroviral therapy.
Five studies included participants who were not on com-
bination antiretroviral therapy; however, others reported
including participants taking some form of antiretroviral
medication [38, 48–50] (Table 1).
Eleven studies included participants living with add-
itional health-related conditions (in addition to HIV).
Nine studies included participants with forms of hyper-
lipidemia [52], dyslipidemia [30, 33], lipodystrophy [28,
30], changes in fat distribution [44, 46, 51], hyperinsuli-
nemia [44], insulin resistance, glucose intolerance and
central adiposity [25], and metabolic syndrome [31].
One study included participants with AIDS wasting [42].
One study included participants who were co-infected
with Hepatitis C and on methadone maintenance who
were prison inmates [27]. Other personal characteristics
were reported inconsistently across studies (Table 1).
Outcomes of included studies
All except two included studies (92 %) assessed im-
munological or virological outcomes or both, in the
form of CD4 count or viral load [29, 34]. Twenty of the
24 included studies (83 %) assessed cardiorespiratory
outcomes [26–28, 30–33, 36, 38, 40, 44, 46–54]. Eleven
of the 24 included studies (46 %) assessed strength out-
comes [26, 27, 30–32, 38, 42, 44, 47, 48, 51]. Eighteen of
the 24 included studies (75 %) assessed weight and body
composition outcomes [25–28, 30–34, 38, 40, 42, 44, 46,
48, 51, 52, 54]. Thirteen of the 24 included studies
(54 %) assessed psychological outcomes in the form of
anxiety and depression, health status, depression, mood
and life satisfaction, and health-related quality of life
[26–29, 36, 38, 40, 46, 48–50, 53, 54]. Safety in the form
of monitoring adverse events was reported in nine of the
24 studies (38 %) [25, 27, 29, 31–33, 47, 48, 51]
(Table 2).
Correspondence with authors
We wrote to authors of 11 included studies for clarifica-
tion and additional data, three of whom responded. Yar-
asheski provided additional data including mean change
and standard deviations of body mass index outcomes
and viral load outcomes [25]. Agostini clarified the inter-
vention included a combination of aerobic and resistive
exercise and provided more details on the intervention.
Authors indicated they were not able to provide raw
data on body weight, fat mass, muscle mass, or waist cir-
cumference (data were reported as % increase or de-
crease) [34]. We requested SF-36 Physical Component
Scores (PCS) and Mental Component Scores (MCS)
from Tiozzo who responded with data on the eight SF-
36 sub-scale scores [26].
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review
Study Immunological/
Virological
Cardiorespiratory Strength Weight and Body
Composition
Psychological Adverse Events Authors’ Conclusions
Agostini
(2009)a [34]
Not assessed Not assessed Not assessed Body Fat: Decrease in
abdominal fat was
similar in both groups.
There did not appear
to be a significant
difference between
groups.
Not assessed Not reported Aerobic exercise and a
balanced diet are key
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
Study Immunological/
Virological
Cardiorespiratory Strength Weight and Body
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Psychological Adverse Events Authors’ Conclusions
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
Study Immunological/
Virological
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Not assessed No deaths or
adverse events.
Exercise has a significant
effect on lean body
mass and muscle area
independent of
testosterone. Muscle











muscle mass and offers
cardio protective effects
by increasing the HDL
cholesterol in men with
AIDS wasting. Exercise
may be a strategy to



















10 % change in VO2
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dejection subscale of the
profile of mood state
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Not reported Aerobic exercise is a
beneficial stress
management intervention
which may be a useful
strategy for attenuating
















Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
Study Immunological/
Virological
Cardiorespiratory Strength Weight and Body
Composition
Psychological Adverse Events Authors’ Conclusions
Lindegaard
(2008)a [30]
Not reported VO2max: Significant increase
in VO2max by 14.4 % in
the aerobic group with
no difference in the PRE
group. Greater improvement
in VO2max in the AEROBIC
group versus the PRE group.
Significant increase
in strength by 30 %
in the PRE group
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
Study Immunological/
Virological
Cardiorespiratory Strength Weight and Body
Composition
Psychological Adverse Events Authors’ Conclusions
in compliant exercisers
(n = 6) for V02 max (24 %),
minute ventilation (13 %),
and oxygen pulse (24 %).
At 12 weeks HR rate
pressure product and
RPE all decreased
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Not assessed Not assessed Not assessed Not assessed Quality of Life: Physical
and mental health
component summary
scores of the SF36
questionnaire improved
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rehabilitation program
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exercises for patients
on HAART. Results show
a significant increase in
all domains of quality
of life with a possible
achievement of an
increase in the function
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in body mass index
(BMI), percent body










in sum of skim folds,
Quality of Life: Significant
improvements in quality





of QOL, and overall QOL





































Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
Study Immunological/
Virological
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and percent body
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Quality of Life: All SF36
domain scores improved
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all domains in both
groups except for the
pain domain (whereby
the control group was
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with nutritional guidance
in people living with HIV
significantly improves
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
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rate peak (bpm) among
exercisers. A significant
combined effect of group
and time was found for
peak-completed workload
(W), HRpeak, and rate
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increases in aerobic capacity
were shown in the exercise
group with no change in
non-exercising control group.
Heart Rate and Total Time to
Voluntary Exhaustion:
Significant decreases in
HR and increases in total
time exercise to voluntary
exhaustion
Significant increases
in chest press and
leg extension in
the exercise group.
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
Study Immunological/
Virological
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Composition
















were able to stay on





Rate of Perceived Exertion
(RPE): No significant
effect on RPE or FEV1 in
either group (dyspnea).
Significant improvements
in V02max in the
experimental group







































































training effect was seen
(heavy >moderate)
relative to the non-
exercising control group.
VO2max and Work Rate
Max and Lactic Acid
Threshold: Significant
increases in V02 max
and Work Rate max in
the heavy exercise group.
LAT increased significantly
in both intervention groups.
























training is safe and
effective in this group
and should be promoted
for HIV+ individuals.
Terry (1999) [54] CD4 count: No
significant
changes.
HRMax: Peak HR was
unchanged for both
groups; peak systolic BP
increased significantly
only in high intensity
group.
Not assessed Body Composition:
No significant change
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
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HRmax: No significant
changes in either group.
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withdrew from
the study due to
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HIV positive adults with
hyperlipidemia, when
engage in 3 months of
aerobic exercise and a
low lipid diet do not
experience significant
changes in triglycerides,
total cholesterol, or HDL
cholesterol levels (not
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Table 2 Outcomes and Author’s Conclusions of Individual Studies Included in the Aerobic Exercise and HIV Systematic Review (Continued)
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that includes diet and
exercise is more effective
than medication
interventions alone.
HRQL health-related quality of life, QOL quality of life, MOS-HIV Medical Outcomes Study HIV Scale, VO2max maximum oxygen consumption, 6MWT 6 min walk test, BMI body mass index















An overview of risk of bias of included studies is pro-




Authors of all 24 included studies reported that they
used randomization to allocate participants to the com-
parison groups. However, an overall unclear risk for
selection bias exists as 13 of the 24 included studies
(54 %) did not include a description of the randomization
process [25, 27, 28, 30, 32, 34, 36, 38, 40, 46–48, 54]. Low
risk for selection bias was evident in the remaining eleven
studies (46 %) that described the randomization process
[26, 29, 31, 33, 42, 44, 49–53] (Fig. 2).
Allocation concealment
Overall an unclear risk of selection bias exists as 18 of
the 24 included studies (75 %) did not describe the allo-
cation sequence of participants. Six of the 24 included
studies (25 %) had low risk for selection bias describing
methods to conceal the allocation sequence of partici-
pants [27, 42, 44, 46, 50, 51] (Fig. 2).
Blinding
Performance bias
Overall a high risk of performance bias exists across the
included studies. Twenty-one of the 24 included studies
(88 %) had a high risk for performance bias because par-
ticipants were not blinded to the exercise intervention.
Of these, five studies reported single-blinding of study
personnel who were assessing outcomes to the group al-
location [27, 29, 31–33]. In two studies, participants
were blinded to co-interventions including metformin
[31] and testosterone [42]. Nevertheless, we considered
all of the above studies as high risk for bias given the in-
ability to blind participants to the exercise intervention
(Fig. 2). Unclear risk of performance bias occurred in
three studies. In studies that compared aerobic to resist-
ive exercise, different intensities of exercise, or where
both comparison groups included some form of exercise,
blinding was unclear [30, 34]. In MacArthur [53], partic-
ipants were not told whether they had been randomized
to the low-intensity group or the high-intensity group
but it is unclear whether study personnel were blinded
[53] (Fig. 2).
Detection bias
Overall an unclear risk of detection bias exists as 19 of
the 24 included studies (79 %) did not provide sufficient
information to determine whether study personnel were
blinded to the outcome assessment. Five studies (21 %)
had low risk for detection bias reporting blinding of
study personnel who were assessing outcomes to group
allocation [27, 29, 31–33] (Fig. 2).
Incomplete outcome data (Attrition Bias)
Overall 303 participants withdrew from the included
studies resulting in an overall ~24 % withdrawal rate
(303/1242 participants at baseline). Withdrawal rates
within individual studies ranged from 0 % [32, 38] to
76 % [53] (Table 1). Overall a high risk of attrition bias
exists as 16 of the 24 included studies (67 %) reported
withdrawal rates >15 %. The remaining eight included
studies had low risk of attrition bias (33 %) with with-
drawal rates less than 15 % [25, 28, 30, 32, 34, 38, 46,
51] (Fig. 2).
Withdrawal rates were similar between comparison
groups for the majority of included studies. Three stud-
ies reported differences in the characteristics of partici-
pants who withdrew from the study [29, 33, 50] with
more women and/or African Americans withdrawing
from two studies [29, 50] and older participants with less
familial history of diabetes remaining in the other study
[33]. Twenty-three of the 24 included studies (96 %)
Fig. 2 Cochrane Risk of Bias of Included Studies (n = 24 studies)
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made reference to participants who withdrew from or
were non-adherent (or non-compliant) with the inter-
vention. Withdrawal rates were not reported by LaPer-
riere [36]. Rates of withdrawal for individual studies are
provided in Table 1.
Adherence to the exercise intervention was reported
in nine of the 24 included studies (38 %) with adherence
rates ranging from 61 % to 100 % [25–27, 30, 32, 46, 48,
51, 52]. Mutimura [45] reported an 82 % adherence rate
and [48] reported 61 % of participants were adherent
with the exercise intervention. Both studies defined ad-
herence as attending >50 % of the exercise sessions [46,
48]. Farinatti [32] reported an 87 % adherence rate; Yara-
sheski [25] a 92 % adherence rate; and Perez-Moreno
[27] an overall adherence rate to the intervention of
71 % [25, 27, 32]. Terry [52] reported that adherence to
the exercise sessions was 100 % in both groups [52].
Dolan [51] reported that participants in the exercise
group completed 96 % of the total exercise interventions.
Tiozzo [26] reported that participants in the exercise
group attended on average 81 % of the supervised exer-
cise sessions [26]. Lindegaard [30] reported that adher-
ence to exercise was 99 % and 96 % in the aerobic and
resistive exercise groups, respectively. All nine of the
studies that reported on adherence also supervised the
exercise intervention [25–27, 30, 32, 46, 48, 51, 52].
MacArthur [53] reported six out of 25 of the partici-
pants were compliant with the exercise program
(attended >80 % of the sessions), seven were somewhat
compliant (attended 30–80 % of sessions) and 12 were
not compliant (attended <30 % of sessions) [53]. Super-
vision of the exercise intervention was not reported in
this study.
Selective reporting (Reporting Bias)
Overall a low risk of reporting bias exists as the majority
of included studies; 20/25 (83 %) were free of selective
outcome reporting as authors provided data on all pre-
specified outcomes. Four studies (17 %) had incomplete
or inconsistent data [28, 33, 34, 53]. Agostini [34] pro-
vided outcome data for body weight, fat mass, muscle
mass and waist circumference in % increase or decrease
only. Authors responded to our request stating that they
did not have access to the raw data. Balasubramanyam
[33] did not report all outcomes for body composition
and cardiorespiratory fitness. MacArthur [53] only re-
ported on six of the participants who were compliant
with the exercise intervention [53]. In Ogalha [28], the
data across tables are inconsistent and authors did not
report data for all outcomes such as viral load (Fig. 2).
Other potential sources of bias
Overall a low risk for other sources of potential bias ex-
ists as the majority of studies (92 %) appeared free from
other problems that could place a study at high risk of
bias. Two studies possessed unclear risk of additional
bias [32, 33]. Balasubramanyam [33] reported receiving >
$10,000 funding from Abbott and research support
from consultancy fees [33]. In Farinatti [32], a higher
number of participants were assigned to the exercise
group to maintain the sample size at study completion if
adherence to exercise was low; it is unclear if this may
have skewed results [32].
Group similarity at baseline
Sixteen of the 24 included studies (67 %) reported that
comparison groups were similar at baseline [25, 27, 29–
32, 34, 36, 40, 44, 46–50, 54]. MacArthur [53] and Grin-
spoon [42] did not report on group similarity at baseline
[42, 53]. Lox [38] indicated significant differences be-
tween comparison groups for “most” participant charac-
teristics, but variables that were different between the
groups were not specified. Dolan [51] indicated that the
exercise group had more endurance and knee strength
at baseline. Terry [52] indicated that the low lipid diet
group had a small but significantly higher haemoglobin
level compared with the combined exercise and low lipid
diet group [52]. Balasubramanyam [33] indicated that
the family history of diabetes was less frequent in the
diet and exercise intervention group compared with the
non-exercising control group. Ogalha [28] indicated a
small but significant difference in baseline fasting total
cholesterol and high-density lipoprotein cholesterol
closer to normality levels in the control group compared
with the exercise group (mean rates were higher in the
exercise group at baseline). Tiozzo [26] indicated that a
higher number of participants in the exercise group had
a smoking history compared with the control group pla-
cing them at higher risk of cardiovascular disorders. Fas-
ter mean heart rate recovery was evidence among
participants in the control group compared with the ex-
ercise group at baseline [26].
Meta-analyses - effects of interventions
Seventy-five meta-analyses were completed across eight
sub-group comparisons in this review (17 of which in-
cluded similar studies) resulting in 58 unique meta-
analyses to this systematic review. Meta-analyses were
performed for immunological and virological outcomes
(CD4 count, CD4 percentage, and viral load), cardiore-
spiratory outcomes (VO2max, HRmax, exercise time),
strength outcomes (chest press, leg press, knee exten-
sion, knee flexion, upper and lower body strength),
weight and body composition outcomes (body weight,
body mass index, lean body mass, fat mass, percent body
fat, leg muscle area, waist circumference, hip circumfer-
ence, waist-to-hip ratio), and psychological outcomes
(quality of life, depression-dejection symptoms).
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Of the 58 unique meta-analyses, 28 were new to this
systematic review update, 16 were updated with add-
itional studies, and 14 were the same as in the previous
review [10]. Subgroup comparisons of the meta-analyses
included 1) constant or interval aerobic exercise or com-
bined aerobic and progressive resistive exercise (PRE)
versus no exercise; 2) constant or interval aerobic exer-
cise versus no exercise; 3) constant aerobic exercise ver-
sus no exercise; 4) interval aerobic exercise versus no
exercise; 5) moderate-intensity aerobic exercise versus
heavy-intensity aerobic exercise; 6) constant or interval
aerobic exercise combined with PRE versus no exercise;
7) aerobic exercise versus PRE; and 8) combined aerobic
exercise and diet and/or nutrition versus diet and/or nu-
trition only.
Fifteen of the 24 included studies compared constant
or interval aerobic exercise or combined aerobic and
progressive resistive exercise (PRE) with a non-
exercising control group [26, 27, 29, 31, 32, 36, 38, 40,
42, 46–51]. Eight studies compared constant or interval
aerobic exercise with a non-exercising control group [29,
36, 38, 40, 46, 48–50]. Seven studies compared com-
bined aerobic and PRE [26, 27, 31, 32, 42, 47, 51]. Two
studies compared aerobic with PRE [30, 38]. Three stud-
ies did not include a non-exercising control group [30,
53, 54] (Table 1). Driscoll [44] and Fitch [31] included
aerobic and PRE combined with metformin compared
with metformin only but we were unable to combine
outcomes in meta-analysis. Terry [52], Ogalha [28], Bala-
subramanyam [33], and Agostini [34] included aerobic
exercise or aerobic combined with PRE combined with a
lipid diet and/or nutrition counselling versus diet and/or
nutritional counselling alone. Yarasheski [25] included
aerobic and PRE combined with pioglitazone versus pio-
glitazone only (Table 1).
The number of meta-analyses was limited due to vari-
ability in types of exercise interventions (aerobic exercise
vs. combined aerobic and PRE exercise), level of exercise
supervision, types of outcomes reported, and methodo-
logical quality. Aerobic interventions in the trials varied
according to constant compared to interval exercise and
moderate compared to heavy intensity exercise, and
combined aerobic and resistive exercise compared to
aerobic exercise alone. See Table 1 for characteristics of
included studies and descriptions of specific interven-
tions in individual studies.
Heterogeneity
Heterogeneity (p < 0.1) was evident in 31 of the 58
unique meta-analyses (53 %). Reasons for heterogeneity
may include differences in the types of participants in
relation to antiretroviral use, body composition, comor-
bidity, gender, type and location of intervention, as well
as methods of outcome measurement. We conducted
sensitivity analyses on 18 of the 31 meta-analyses with
heterogeneity (those with greater than two studies in-
cluded in the meta-analysis. We discuss the specific sen-
sitivity results and reasons for heterogeneity within the
analyses below.
Immunological and virological outcomes
Twenty-two of the 24 included studies (92 %) assessed im-
munological or virological outcomes, or both, in the form
of CD4 count or viral load. Fourteen of the studies
included a non-exercising control group, seven of which
included combined interventions of aerobic and PRE
[26, 27, 31, 32, 42, 47, 51]. Seven studies also measured im-
munological and virological outcomes but did not include a
non-exercising control group [25, 28, 33, 44, 52–54].
CD4 count (cells/mm3)
Seven meta-analyses were performed for CD4 count.
The majority (6 out of 7 meta-analyses) demonstrated
no statistically significant changes in CD4 count between
comparison groups (Table 3). Results demonstrated a
non-significant trend towards an increase in change in
CD4 count for participants in the aerobic or combined
aerobic and PRE intervention group compared with the
non-exercising control group; constant or PRE com-
pared with no exercise; and significant increase in CD4
count for interval aerobic exercise compared with no ex-
ercise (Table 3). The point estimate in the latter two
meta-analyses was above 50 cells/mm3, which suggests a
trend towards a potential clinically important improve-
ment in CD4 count among exercisers compared with
non-exercisers.
Meta-analyses resulted in no difference in change in
CD4 count for constant or interval aerobic exercise
compared with no exercise; constant aerobic exercise
compared with no exercise; as well as combined aerobic
exercise and diet and/or nutrition counselling group
compared with diet and/or nutrition counselling alone
(Table 3). Similarly, no difference in change in CD4
count was found for participants exercising at moderate
compared with heavy intensity (Table 3).
Heterogeneity - CD4 Count
Six of the seven meta-analyses were statistically signifi-
cant for heterogeneity (p < 0.1). Sensitivity analyses were
conducted for five of the meta-analyses with greater than
two studies. While removing combinations of studies re-
duced heterogeneity, sensitivity analyses did not change
the overall effect of exercise on CD4 count beyond clin-
ical importance.
CD4 percentage
Three meta-analyses were performed for CD4 percentage,
two of which included similar studies. Meta-analyses
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Table 3 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Immunological and Virological Outcomes
Outcomes Sub-Group Comparison
of Meta-Analysis



























Dolan 2006 [51]; Farinatti 2010
[32]; Fitch 2012 [31]; Grinspoon
2000 [42]; LaPerriere 1990
[35, 36] ; Lox 1995 [38];
Mutimura 2008a [45]; Perez-
Moreno 2007 [27]; Perna
1999 [48]; Rigsby 1992 [47];
Smith 2001 [40]; Stringer
1998 [49], Tiozzo 2011 [26])
479 37.43
cells/mm3
−0.16, 75.01 0.05 92 %
(p <
0.00001)
No difference in change in CD4 count
among exercisers compared with
non-exercisers. Confidence interval
indicates a positive trend towards
an improvement in CD4 count
among exercisers.




Farinatti 2010 [32]; Fitch
2012 [31]; Grinspoon
2000 [42]; Perez-Moreno




−1.27, 116.91 0.06 74 %
(p = 0.0008)
No difference in change in CD4
count among exercisers compared
with non-exercisers. Confidence
interval indicates a positive trend
towards an improvement in CD4
count among exercisers.
Interval aerobic exercise
compared with no exercise
2 studies
(LaPerriere 1990
[35, 36]; Perna 1999) [48]
45 69.58
cells/mm3b
14.08, 125.09 0.01a 64 %
(p = 0.09)
Significant increase in CD4 count
for interval aerobic exercise
compared with no exercise
Constant or interval aerobic




LaPerriere [35, 36] 1990;
Lox 1995 [38]; Mutimura
2008a [45]; Perna 1999




−11.82, 47.99 0.24 82 %
(p < 0.0001)
No difference in change in CD4
count among exercisers compared
with non-exercisers.
Constant aerobic exercise
compared with no exercise
5 studies
(Baigis 2002 [50];
Lox 1995 [38]; Mutimura
2008a [45]; Smith 2001
[40]; Stringer 1998 [49])
261 −3.11
cells/mm3
−31.06, 24.84 0.83 74 %
(p = 0.004)
No difference in change in CD4
count among exercisers compared
with non-exercisers.
Combined aerobic exercise
and diet and/or nutrition
counselling group compared








66.10, 18.92 0.28 80 %
(p = 0.006)
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count for participants exercising















Table 3 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Immunological and Virological Outcomes (Continued)
Outcomes Sub-Group Comparison
of Meta-Analysis





















Aerobic (constant or interval)
exercise or combined aerobic




Farinatti 2010 [32]; Smith
2001 [40])
145 0.63 % −1.32, 2.59 0.53 88 %
(p = 0.0003)













118 −0.33 % −1.98, 1.32 0.69 76 %
(p = 0.04)






Aerobic (constant or interval)
exercise or combined aerobic




Fitch 2012 [31]; Grinspoon





−0.13, 0.48 0.27 0 %
(p = 0.68)
No difference in change in viral
load among exercisers compared
with non-exercisers.
Aerobic exercise intervention
group compared with no
exercise AND
Constant aerobic







−0.28, 1.07 0.25 0 %
(p = 0.88)
No difference in change in viral
load among exercisers compared
with non-exercisers.
Combined aerobic and PRE




Fitch 2012 [31]; Grinspoon
2000 [42], Tiozzo 2011 [26])
99 0.12 log10
copies
−0.23, 0.46 0.51 0 %
(p = 0.46)
No difference in change in viral
load among exercisers compared
with non-exercisers.
aindicates statistical significance














demonstrated no difference in change in CD4 percentage
for participants in the constant aerobic exercise group
compared with the non-exercising control group; and no
difference for participants in the aerobic or combined aer-
obic and PRE group compared with the non-exercising
control group (Table 3).
Heterogeneity - CD4 percentage
One meta-analysis was statistically significant for hetero-
geneity (P < 0.1) (Table 3). Sensitivity analysis did not
reduce heterogeneity, which was likely attributed to dif-
ferences in characteristics of participants in the included
studies.
Viral load (log10copies)
Four meta-analyses were performed for viral load, two
of which included the same studies. Meta-analyses
demonstrated no difference in change in viral load for
participants in the aerobic exercise intervention group
compared with the non-exercising control group as well
as the constant aerobic exercise group compared with
the non-exercising control group; no difference in the
combined aerobic and PRE group compared with the
non-exercising control group; and no difference for par-
ticipants in the aerobic or combined aerobic and PRE
intervention group compared with the non-exercising
control group (Table 3). None of the meta-analyses were
significant for heterogeneity.
GRADE rating - viral load
We are moderately confident in the non-significant effect
estimate of 0.18 log10copies in viral load demonstrating
no difference in change in viral load comparing aerobic
exercise (or combined aerobic and PRE). The true effect is
likely to be close to the estimate of effect, but there is a
possibility that it may be substantially different. This out-
come was downgraded from high to moderate GRADE
quality of evidence due to incomplete outcome data (with-
drawals of included studies were >15 %) (see Additional
file 2 – GRADE Summary of Findings Table).
Cardiorespiratory outcomes
Twenty of the 24 included studies (83 %) assessed cardio-
respiratory outcomes, 13 of which compared aerobic or
combined aerobic and PRE to non-exercise [26, 27, 31, 32,
36, 38, 40, 46–51]; seven of which compared constant or
interval aerobic exercise to non-exercising control
[36, 38, 40, 46, 48–50], three of which compared mod-
erate aerobic exercise with heavy aerobic exercise [49, 53,
54], and six of which compared constant or aerobic exer-
cise and PRE to non-exercising control [26, 27, 31, 32, 47,
51]. Driscoll [44] and Fitch [31] measured cardiorespira-
tory outcomes but compared exercise to metformin. Terry
[52], Ogalha [28], and Balasubramanyam [33] measured
cardiorespiratory outcomes but compared exercise com-
bined with diet and/or nutritional counselling (Table 1).
VO2max
Six meta-analyses were performed for VO2max, five of
which were significant favouring exercise compared with
non-exercise. Meta-analyses showed a significant im-
provement in change of VO2max of 2.63 mL/kg/min for
participants in the aerobic exercise intervention group
compared with the non-exercising control group (Table 4);
significant improvement in change of VO2max of
2.40 ml/kg/min for participants in the constant aerobic
exercise group compared with the non-exercising control
group (Table 4); significant improvement in VO2max of
3.71 ml/kg/min for participants in the combined aerobic
and PRE group compared with the non-exercising control
group (Table 4); significant improvement of 2.87 ml/kg/
min for participants in the aerobic or combined aerobic
and PRE group compared with non-exercising control
group (Table 4); and a significant trend towards a greater
improvement in VO2max of 4.30 mL/kg/min for partici-
pants in the heavy-intensity exercise group compared with
the moderate-intensity exercise group (Table 4). No sig-
nificant difference in change in VO2max was found for
participants in the combined aerobic exercise and diet or
nutrition counselling group compared with the diet or nu-
trition counselling group only (Table 4). All point esti-
mates were greater than 2 mL/kg/min, which suggest a
potential clinically important improvement in VO2max
among exercisers and a greater improvement with heavy-
versus moderate-intensity exercise.
Heterogeneity - VO2max
Four of six meta-analyses were statistically significant for
heterogeneity (p < 0.1). Sensitivity analyses (three per-
formed) indicated that removing Mutimura [45] from
the aerobic versus non-exercise comparison, constant
exercise versus non-exercise comparison, and aerobic or
combined aerobic and PRE comparison successfully re-
duced heterogeneity. Results for overall effect remained
statistically significant favouring exercise; however, the
point estimate was reduced to 1.64 mL/kg/min (95 % CI:
1.06, 2.22), 1.53 mL/kg/min (95 % CI: 0.94, 2.12), and
1.99 mL/kg/min (95 % CI: 1.25, 2.73) respectively (not
shown), which are below the threshold for clinical
importance. Reasons for heterogeneity may be due to
differences in characteristics of participants in the Muti-
mura [45] study; they were from Rwanda and all pos-
sessed moderate to severe body fat redistribution.
GRADE rating - VO2max
We have very little confidence in the effect estimate
demonstrating a significant increase of 2.87 ml/kg/min
for VO2max comparing aerobic exercise (or combined
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Table 4 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Cardiorespiratory Outcomes
Outcomes Sub-Group Comparison of
Meta-Analysis




















Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
8 studies
(Baigis 2002 [50]; Dolan 2006 [51];
Fitch 2012 [31]; Mutimura 2008a
[45]; Perna 1999 [48]; Smith




1.69, 4.04 <0.0001a 67 %
(p = 0.003)
Significant (and potential clinically
important) improvement in change
in VO2max among exercisers
compared with non-exercisers.
Aerobic exercise (constant or
interval) compared with no
exercise
5 studies
(Baigis 2002 [50]; Mutimura 2008a
[45]; Perna 1999 [48]; Smith 2001
[40]; Stringer 1998 [49])
276 2.63 ml/
kg/minb
1.19, 4.07 0.0003a 79 %
(p = 0.0008)
Significant (and potential clinically
important) improvement in change
in VO2max among exercisers
compared with non-exercisers.
Constant aerobic exercise group
compared with no exercise
4 studies
(Baigis 2002 [50]; Mutimura 2008a




0.82, 3.99 0.003a 83 %
(p = 0.0006)
Significant (and potential clinically
important) improvement in change
in VO2max among exercisers
compared with non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
3 studies




1.73, 5.70 0.0002a 0 %
(p = 0.84)
Significant (and potential clinically
important) improvement in change
in VO2max among exercisers
compared with non-exercisers.
Heavy versus moderate intensity
exercise
2 studies




0.61, 7.98 0.02a 67 %
(p = 0.99)
Greater (and potential clinically
important) improvement in VO2max
for participants in the heavy-intensity
exercise group compared with the
moderate-intensity exercise group.
Combined aerobic exercise and
diet or nutrition counselling
group compared with diet or
nutrition counselling alone
2 studies
(Ogalha 2011 [28]; Terry 2006 [52])
93 3.36 ml/
kg/minb
−3.03, 9.75 0.30 88 %
(p = 0.004)
No significant difference in change
in VO2max was found for
participants in the combined
aerobic exercise and diet or
nutrition counselling group





Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
4 studies
(Lox 1995 [38]; Perez-Moreno 2007





−22.52, 7.87 0.34 97 %
(p < 0.00001)
Non-significant trend towards a
decrease in heart rate maximum
among exercisers compared with
non-exercisers.
Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
2 studies




−26.28, 6.67 0.24 92 %
(p = 0.0003)
Non-significant trend towards a
decrease in heart rate maximum
among exercisers compared with
non-exercisers.
Combined aerobic and PRE








−34.13, 24.30 0.74 99 %
(p < 0.00001)
No significant difference in change
















Table 4 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Cardiorespiratory Outcomes (Continued)
Outcomes Sub-Group Comparison of
Meta-Analysis




















Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
4 studies
(Dolan 2006 [51]; Fitch 2012 [31];
Rigsby 1992 [47]; Smith 2001 [40])
129 2.66 min 0.12, 5.19 0.04a 98 %
(p < 0.00001)
Significant increase in exercise time
among exercisers compared with
non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
3 studies
(Dolan 2006 [51]; Fitch 2012 [31];
Rigsby 1992 [47])
83 3.29 min 0.10, 6.49 0.04a 97 %
(p < 0.00001)
Significant increase in exercise time
among exercisers compared with
non-exercisers.
bpm beats per minute
aindicates statistical significance














aerobic and PRE) with non-exercising control. The true
effect is likely to be substantially different from the esti-
mate of effect (Table 4). This outcome was downgraded
from high to very low on the GRADE quality of evidence
due to incomplete outcome data (withdrawals of in-
cluded studies >15 %), suspected publication bias, sub-
stantial heterogeneity (I2 = 67 %); and because the
lower level of the confidence interval did not cross
the estimated clinically important change in VO2max
(despite the estimate surpassing our hypothesized
clinically important change in VO2max of 2 ml/kg/
min) (see Additional file 2 – GRADE Summary of
Findings Table).
Maximum Heart Rate (HRmax)
Three meta-analyses were performed and showed a non-
significant trend towards a decrease in HRmax of −9.81
beats/min, 7.33 beats/min and 4.91 beats/min for partici-
pants in the aerobic exercise intervention group compared
with the non-exercising control group; aerobic or combined
aerobic and PRE group compared with the non-exercising
control; and combined aerobic and PRE compared with
non-exercising control (Table 4), respectively.
Heterogeneity - maximum heart rate
Heterogeneity was present in all three meta-analyses
(p < 0.1). Removing Perna [48] and Perez-Moreno [27]
removed heterogeneity from the aerobic exercise or com-
bined aerobic and PRE intervention versus non-exercise
control comparison and the overall effect demonstrated a
small but significant decrease in maximum heart rate
of −19.21 beats per minute [95 % CI: −22.87, −15.55]
(not shown). Reasons for heterogeneity may be due to
differences in characteristics of participants in the in-
cluded studies; participants in Perez-Moreno [27]
were all in prison and co-infected with Hepatitis C.
Exercise time
Two meta-analyses were performed and significant in-
creases in exercise time of 3.29 min were found for partic-
ipants in the combined aerobic and PRE group compared
with the non-exercising control group (Table 4); and
2.66 min for participants in the aerobic or combined aer-
obic and PRE group compared with the non-exercising
control group (Table 4). Point estimates did not reach the
5 min threshold for clinical importance.
Heterogeneity - Exercise time
Both meta-analyses were statistically significant for het-
erogeneity (p < 0.1). Removing Rigsby [47] and Smith [40]
from the aerobic exercise or combined aerobic and PRE
intervention versus non-exercise control comparison and
Rigsby [47] from the combined aerobic and PRE versus
non-exercise control comparison removed heterogeneity
and the overall effect remained significant, but was re-
duced to 1.72 min [95 % CI: 1.03, 2.42] among exercisers
compared with control (not shown). Reasons for hetero-
geneity may be due to differences in characteristics of par-
ticipants in the included studies.
See Table 2 for individual study results for outcomes
unable to be combined in meta-analyses.
Strength outcomes
Eleven of the 24 included studies (46 %) assessed strength
outcomes [26, 27, 30–32, 38, 42, 44, 47, 48, 51]. Ten meta-
analyses were performed, four of which included duplicate
studies. Meta-analyses demonstrated significant improve-
ments in upper and lower body strength as measured by
increases in 1-repetition maximum for chest press, and
knee flexion; and a non-significant improvement (trend)
towards increases in 1-RM for leg press and knee extension
for participants in the combined aerobic and PRE group
versus non-exercising control group (Table 5). Two meta-
analyses were conducted comparing aerobic versus resist-
ive exercise. Significantly greater increases in strength were
found among participants in the PRE group compared with
participants in the aerobic exercise only group for upper
and lower muscle groups (Table 5).
All six point estimates for upper and lower extremity
strength are greater than 2 kg and 5 kg respectively indi-
cating a clinically important greater increase in strength
for resistive exercisers compared with aerobic exercise.
Heterogeneity - Strength
Heterogeneity was present in four meta-analyses. Re-
moving Grinspoon [42] from the combined aerobic and
PRE versus control comparison reduced heterogeneity
(p = 0.95) for knee extension and the overall effect be-
came significant for exercise compared with no exercise.
Reasons for heterogeneity may be attributed to differ-
ences in study participants. Participants in Grinspoon
[42] had signs of AIDS-related wasting.
GRADE ratings - Strength
Our confidence is limited in the effect estimate of a sig-
nificant increase of 11.86 kg for 1-repetition maximum
for chest press comparing aerobic exercise (or combined
aerobic and PRE) with non-exercising control. The true
effect may be substantially different from the estimate of
effect (Table 5). This outcome was downgraded from
high to low on the GRADE quality of evidence due to
incomplete outcome data (withdrawals of included stud-
ies were >15 %), publication bias suspected, and moder-
ate heterogeneity (I2 = 46 %). However, the estimate
demonstrated a significant effect for improvement in
chest press and the lower limit of the confidence interval
surpassed our hypothesized clinically important change
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Table 5 Results of Meta-Analyses in Aerobic Exerciser and HIV Systematic Review: Strength Outcomes
Outcomes Sub-Group Comparison of
Meta-Analysis






















Combined aerobic and PRE





44 11.86 kg 1-RMb 2.37, 21.36 0.01a 46 %
(p = 0.18)
Significant (and potential clinically important)
improvement in change in chest press




Combined aerobic and PRE
group compared with no
exercise
3 studies
(Dolan 2006 [51], Fitch
2012 [31]; Grinspoon
2000 [42])
81 10.46 kg 1-RMb 1.64, 19.29 0.02a 91 %
(p < 0.00001)
Significant (and potential clinically important)
improvement in change in knee flexion




Combined aerobic and PRE





44 50.96 kg 1-RMb −13.01, 114.92 0.12 88 %
(p = 0.004)
Non-significant trend towards an





Combined aerobic and PRE
group compared with no
exercise
3 studies
(Dolan 2006 [51]; Fitch
2012 [31]; Grinspoon
2000 [42])
81 20.58 kg 1-RMb −4.69, 45.86 0.11 95 %
(p < 0.00001)
Non-significant trend towards an
increase in knee extension 1-RM





Aerobic versus PRE 2 studies
(Lindegaard 2008
[30]; Lox 1995 [38])
41 14.56 kg 1-RM or
3-RMb
10.63, 18.49 <0.00001a 32 %
(p = 0.23)
Significantly (and potential
clinically important) greater increase
in strength among participants in





Aerobic versus PRE 2 studies
(Lindegaard 2008 [30];
Lox 1995 [38])
41 23.09 kg 1-RM or
3-RMb
13.01, 33.18 <0.00001a 75 %
(p = 0.04)
Significantly (and potential
clinically important) greater increase
in strength among participants in
the PRE group compared with
the aerobic group.
1-RM 1 repetition maximum, 3-RM 3 repetitions maximum, PRE progressive resistive exercise
aindicates statistical significance














in upper body strength (see Additional file 2 – GRADE
Summary of Findings Table).
We have very little confidence in the effect estimate of
a non-significant increase of 50.96 kg for 1-repetition
maximum for leg press comparing aerobic exercise (or
combined aerobic and PRE) with non-exercising control.
The true effect is likely to be substantially different from
the estimate of effect (Table 5). This outcome was down-
graded from high to very low on the GRADE quality of
evidence due to incomplete outcome data (withdrawals
of included studies were >15 %), publication bias was
suspected, and there was considerable heterogeneity
(I2 = 88 %). Furthermore, the confidence intervals cross
the clinically important improvement and deterioration
for change in lower body strength (see Additional file 2 –
GRADE Summary of Findings Table).
Weight and body composition outcomes
Eighteen of the 24 included studies assessed weight and
body composition outcomes [25–28, 30–34, 38, 40, 42,
44, 46, 48, 51, 52, 54].
Weight
Fourteen studies assessed body weight [25, 26, 28, 30,
33, 34, 38, 40, 42, 44, 46, 51, 52, 54]. Five meta-analyses
were performed, two of which included the same studies.
Meta-analyses demonstrated no difference in change in
mean body weight for participants in the aerobic exer-
cise group compared with the non-exercising control
group as well as participants in the constant aerobic ex-
ercise group compared with the non-exercising control
group; no difference in the combined aerobic and PRE
group compared with the non-exercising control group;
and no difference in the aerobic or combined aerobic
and PRE group compared with non-exercising control
(Table 6). Results also demonstrated no significant dif-
ference in change in body weight for participants in the
combined aerobic and diet/nutrition counselling group
compared with diet/nutritional counselling group only
(Table 6).
Heterogeneity - Weight
Heterogeneity was present in two of the five meta-
analyses (p < 0.1). Removing Balasubramanyam [33] from
the combined aerobic and diet/nutritional counselling
versus non-exercise control comparison reduced hetero-
geneity (p = 0.24) but the overall effect remained non-
significant (1.34 kg; 95 % CI: −0.24, 2.9) (not shown).
Reasons for heterogeneity may be due to differences in
the comorbidity of participants in the included studies.
In Balasubramanyam [33], participants had dyslipidemia,
in Ogalha [28], 54 % of participants had lipodystrophy
and in Terry [52] participants had hyperlipidemia.
GRADE rating - Weight
We are moderately confident in the effect estimate of a
non-significant increase of 0.38 kg for body weight com-
paring aerobic exercise (or combined aerobic and PRE)
with non-exercising control. The true effect is likely to
be close to the estimate of effect; but there is a possibil-
ity that it is substantially different (Table 6). This out-
come was downgraded from high to moderate on the
GRADE quality of evidence due to incomplete outcome
data (withdrawals of included studies were >15 %), and
moderate heterogeneity (I2 = 48 %). The confidence
interval limits and effect estimate do not cross our esti-
mated clinically important change in body weight (see
Additional file 2 – GRADE Summary of Findings Table).
Body composition
Eighteen studies assessed body composition [25–28, 30–
34, 38, 40, 42, 44, 46, 48, 51, 52, 54]. Twenty-six meta-
analyses were performed, each for body mass index, lean
body mass, fat mass, percent body fat, leg muscle area,
waist circumference, hip circumference, and waist-to-hip
ratio. Eight of the 26 meta-analyses were duplicate and
included the same studies.
Body mass index
Results demonstrated no difference in change in body
mass index for four comparisons of participants in the
aerobic or combined aerobic and PRE group compared
with non-exercising control; constant aerobic exercise
compared with non-exercising control; combined aer-
obic and PRE exercise group compared with non-
exercising control and combined aerobic exercise and
diet/nutrition counselling group compared with diet/nu-
tritional counselling group only (Table 6).
GRADE rating - Body Mass Index
We are very confident with the effect estimate of a non-
significant increase of 0.07 kg/m2 for body mass index
comparing aerobic exercise (or combined aerobic and
PRE) with non-exercising control. The true effect is likely
to be close to the estimate of effect; but there is a possibil-
ity that it is substantially different (Table 6). This outcome
was not downgraded on the GRADE quality of evidence
because this was an objective outcome of interest and
publication bias was not suspected (see Additional file 2 –
GRADE Summary of Findings Table).
Lean body mass
Meta-analyses demonstrated a significant increase in
lean body mass of 1.75 kg for participants in the aerobic
or combined aerobic and PRE group compared with par-
ticipants in the non-exercising control (Table 6), No dif-
ference in lean body mass was found for participants in
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Table 6 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Weight and Body Composition Outcomes
Outcomes Sub-Group Comparison of
Meta-Analysis




















Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
5 studies
(Dolan 2006 [51]; Grinspoon 2000
[42]; Lox 1995 [38]; Smith
2001 [40])
151 0.38 kg −1.55, 2.31 0.70 48 %
(p = 0.10)
No significant difference in
change in body weight among
exercisers compared with
non-exercisers.
Aerobic exercise (constant or




exercise compared with no
exercise
2 studies
(Lox 1995 [38]; Smith 2001 [40])
68 0.37 kg −5.32, 6.05 0.90 71 %
(p = 0.06)
No significant difference in
change in body weight
among exercisers compared
with non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
3 studies
(Dolan 2006 [51]; Grinspoon
2000 [42]; Tiozzo 2011 [26])
83 0.81 kg −0.94, 2.56 0.37 19 %
(p = 0.29)
No significant difference in
change in body weight among
exercisers compared with
non-exercisers.
Combined aerobic exercise and
diet or nutrition counselling




Ogalha 2011 [28]; Terry
2006 [52])
161 −0.58 kg −4.33, 3.17 0.76 93 %
(p < 0.00001)
No significant difference in
change in body weight for
participants in the combined
aerobic exercise and diet or
nutrition counselling group





Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
6 studies
(Dolan 2006 [51]; Farinatti 2010
[32]; Fitch 2012 [31]; Lox 1995
[38]; Mutimura 2008a [45];
Tiozzo 2011 [26])
227 0.07 kg/m2 −0.52, 0.66 0.81 59 %
(p = 0.03)
No significant difference in




compared with no exercise
2 studies
(Lox 1995 [38]; Mutimura
2008a [45])
118 0.06 kg/m2 −1.89, 2.02 0.95 64 %
(p = 0.10)
No significant difference in
change in body mass index
among exercisers compared
with non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
4 studies
(Dolan 2006 [51]; Farinatti
2010 [32]; Fitch 2012 [31];
Tiozzo 2011 [26])
109 0.21 kg/m2 −0.27, 0.68 0.40 0 %
(p = 0.40)
No significant difference in
change in body mass index
among exercisers compared
with non-exercisers.
Combined aerobic exercise and
diet or nutrition counselling




Ogalha 2011 [28]; Terry
2006 [52])
161 −0.57 kg/m2 −1.26, 0.13 0.11 82 %
(p = 0.004)
No significant difference in
change in body mass index
for participants in the
combined aerobic exercise
and diet or nutrition counselling
group compared with the















Table 6 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Weight and Body Composition Outcomes (Continued)
Outcomes Sub-Group Comparison of
Meta-Analysis




















Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
4 studies
(Farinatti 2010 [32]; Grinspoon
2000 [42]; Lox 1995 [38];
Perez-Moreno 2007 [27])
89 1.75 kg 0.13, 3.37 0.03a 16 %
(p = 0.31)
Significant increase in lean
body mass among exercisers
compared with non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
3 studies
(Farinatti 2010 [32], Grinspoon
2000 [42]; Perez-Moreno [27])
68 1.23 kg −0.62, 3.08 0.19 17 %
(p = 0.30)





Combined aerobic and PRE
group compared with no
exercise
2 studies
(Dolan 2006 [51]; Grinspoon
2000 [42])
60 4.79 cm2 2.04, 7.54 0.0007a 11 %
(p = 0.29)
Significant increase in leg





compared with no exercise
2 studies
(Lox 1995 [38]; Mutimura
2008a [45])
119 −1.12 % −2.18, −0.07 0.04a 8 %
(p = 0.30)
Significant decrease in percent
body fat among exercisers
compared with non-exercisers.
Combined aerobic exercise and
diet or nutrition counselling
group compared with diet or
nutrition counselling alone
2 studies
(Ogalha 2011 [28]; Terry
2006 [52])
93 −2.35 % −4.20, −0.50 0.01a 46 %
(p = 0.17)
Significant decrease in percent
body fat among participants
in the combined aerobic
exercise and diet or nutrition
counselling group compared
with the diet or nutrition
counselling group only.
Fat Mass (kg) Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
4 studies
(Dolan 2006 [51]; Fitch 2012
[31]; Grinspoon 2000 [42];
Lox 1995 [38])
102 0.15 kg −0.59, 0.90 0.69 0 %
(p = 0.82)
No difference in change in
fat mass among exercisers
compared with non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
3 studies
(Dolan 2006 [51]; Fitch 2012
[31]; Grinspoon 2000 [42])
81 0.18 kg −0.74, 1.10 0.70 0 %
(p = 0.63)
No difference in change in





Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
5 studies
(Dolan 2006 [51]; Fitch 2012
[31]; Mutimura 2008a [45],
Smith 2001 [40])
224 −2.16 cm −4.86, 0.54 0.12 82 %
(p = 0.0002)




compared with no exercise
2 studies
(Mutimura 2008a
[45]; Smith 2001 [40];
Tiozzo 2011 [26])
142 −3.53 cm −10.25, 3.19 0.30 94 %
(p < 0.0001)
No difference in change in waist
circumference among exercisers
compared with non-exercisers.
Combined aerobic and PRE
group compared with no
exercise
3 studies
(Dolan 2006 [51]; Fitch
2012; [31])
82 −1.33 cm −4.21, 1.54 0.36 37 %
(p = 0.21)






Aerobic (constant or interval)
exercise or combined aerobic
and PRE compared with no
exercise
3 studies
(Mutimura 2008a [45]; Smith
2001 [40])
165 −0.06 cm −0.23, 0.11 0.50 0 %
(p = 0.44)
















Table 6 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Weight and Body Composition Outcomes (Continued)
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Meta-Analysis



















compared with no exercise
2 studies
(Mutimura 2008a [45]; Smith
2001 [40];
Tiozzo 2011 [26])
142 0.11 cm −0.63, 0.85 0.77 35 %
(p = 0.22)





Combined aerobic and PRE
group compared with no
exercise
2 studies
(Mutimura 2008a [45]; Smith
2001 [40])
142 −0.51 cm −1.47, 0.45 0.30 100 %
(p < 0.00001)





and diet or nutrition
counselling group compared
with diet or nutrition
counselling alone
2 studies
(Ogalha 2011 [28]; Terry 2006 [52])
93 0.02 cm 0.01, 0.03 <0.00001a 0 %
(p = 1.00)
Significantly greater increase in
waist-to-hip ratio among
participants in the combined
aerobic exercise and diet or
nutrition counselling group
compared with the diet or















the combined aerobic and PRE exercise group compared
with non-exercising control (Table 6).
Leg muscle area
Results demonstrated a significant increase in change in
leg muscle area of 4.79 cm2 among participants in the
combined aerobic and PRE group compared with the
non-exercising control group (Table 6).
Percent body fat
Results also found a significant decrease in percent body
fat of 1.12 % for participants in the constant aerobic
exercise group compared with participants in the non-
exercising control group and a significantly greater
decrease in percent body fat of 2.35 % among partici-
pants in the combined aerobic exercise and diet or nu-
trition counselling group compared with diet or
nutritional counselling group alone (Table 6).
Fat mass
Results demonstrated no difference in change in fat
mass for two comparisons of participants in the aerobic
or combined aerobic and PRE group compared with
non-exercising control, and combined aerobic and PRE
exercise group compared with non-exercising control
(Table 6).
Waist and hip circumference and waist-to-hip ratio
No significant differences were found in change in waist
circumference, hip circumference or waist-to-hip ratio
for participants in the aerobic or combined aerobic and
PRE group compared with non-exercising control; as
well as participants in the constant aerobic versus exer-
cise groups and combined aerobic and PRE exercise
groups (Table 6). Results found a slightly greater in-
crease in waist to hip ratio of 0.02 (95 % CI: 0.01 to
0.03) for participants in the combined exercise and diet
or nutrition counselling group compared with diet or
nutritional counselling group only however these results
were not clinically important.
Heterogeneity - Body Composition
Heterogeneity was present in five meta-analyses for body
mass index; waist circumference; and waist-to-hip ratio
(p < 0.1). Removing Mutimura [45] from the aerobic or
combined aerobic and PRE exercise intervention versus
non-exercising control comparison reduced heterogeneity
for body mass index (p = 0.41) and waist circumference
(p = 0.16) but the overall effects remained non-significant
(not shown). Removing Balasubramanyam [33] from the
combined aerobic and diet/nutritional counselling versus
non-exercise control comparison reduced heterogeneity
for body mass index (p = 0.48) but the overall effect
remained non-significant (not shown). Reasons for
heterogeneity may be due to differences in participants in
the included studies. The Mutimura [45] study was con-
ducted in Rwanda opposed to the other included studies
conducted in developed countries. In Balasubramanyam
[33], participants had dyslipidemia, in Ogalha [28], 54 %
of participants had lipodystrophy and in Terry [52] partici-
pants had hyperlipidemia.
Psychological outcomes
Thirteen of the 24 included studies (54 %) assessed psy-
chological outcomes in the form of anxiety and depres-
sion, health status, depression, mood and life
satisfaction, and health-related quality of life [26–29, 36,
38, 40, 46, 48–50, 53, 54].
Health-related quality of life
Meta-analyses were performed for the eight sub-scales
of the SF-36 questionnaire (2 studies; 59 participants).
Results demonstrated statistically significant and clinic-
ally important improvements (>10 point change) on sub
scales of mental health, role emotional and physical
functioning sub scale scores, as well as statistically sig-
nificant improvements in role physical, general health,
and energy/vitality sub-scale scores of the SF36 ques-
tionnaire for participants in the aerobic or combined
aerobic and PRE group compared with participants in
the non-exercising control group. Results represent a
clinically important improvement in mental health, role
emotional and physical functioning compared to non-
exercisers. A statistically significant decrease in pain
sub-scale score was found indicating an increase in pain
favouring non-exercisers compared with exercisers. No
difference in change in social functioning was found be-
tween groups (Table 7).
Heterogeneity - Health-related quality of life
Two of the meta-analyses were significant for heterogen-
eity (p < 0.1) however we were unable to conduct sensi-
tivity analyses given only two studies were included in
the meta-analyses.
GRADE rating - Health-related quality of life
We have very little confidence in the effect estimate
demonstrating an improvement of 6.47 in SF-36 sub
scale scores comparing aerobic exercise (or combined
aerobic and PRE) with non-exercising control. The true
effect is likely to be substantially different from the esti-
mate of effect (Table 7). This outcome was downgraded
from high to very low on the GRADE quality of evidence
due to incomplete outcome data (withdrawals of in-
cluded studies were >15 %), publication bias was sus-
pected, and due to variable heterogeneity on specific
meta-analyses of sub scales ranging from (I2 = 0 to
87 %). Nevertheless, the estimates for mental health, role
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Table 7 Results of Meta-Analyses in Aerobic Exercise and HIV Systematic Review: Psychological Outcomes
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4.73 1.72, 7.74 0.002a 0 %
(p = 0.78)
Significant improvement in change in
General Health subscale score favouring
exercisers compared with non-exercisers.
59 Mental
Health
11.58b 1.35, 21.81 0.03a 87 %
(p = 0.006)
Significant (and potential clinically
important) improvement in change in
Mental Health subscale score favouring
exercisers compared with non-exercisers.
59 Role
Physical
6.56 3.17, 9.96 0.0002a 0 %
(p = 0.53)
Significant improvement in change in Role




10.95b 8.19, 13.71 <0.0001a 0 %
(p = 0.40)
Significant (and potential clinically
important) improvement in change in Role
Emotional subscale score favouring
exercisers compared with non-exercisers.
59 Pain −6.59 −9.83, −3.36 <0.0001a 0 %
(p = 0.40)
Significant reduction in change in Pain




16.30b 6.89, 25.72 0.0007a 67 %
(p = 0.08)
Significant (and potential clinically
important) improvement in change in
physical function subscale score favouring
exercisers compared with non-exercisers.
59 Social
Functioning
2.73 −4.84, 10.30 0.48 57 %
(p = 0.13)
No difference in change in Social
Functioning subscale score among
exercisers compared with non-exercisers.
59 Energy/Vitality 5.03 1.33, 8.72 0.008a 0 %
(p = 71)
Significant improvement in change in
Energy/Vitality subscale score favouring
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(p < 0.0001)
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important) improvement in depression-
dejection scores favouring exercisers
compared with non-exercisers.
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emotional and physical function SF-36 sub scales surpass
the estimated clinically important improvement in qual-
ity of life of 10 points; whereas the other 5 statistically
significant sub scale analyses do not surpass the clinic-
ally important improvement estimate (see Additional file
2 – GRADE Summary of Findings Table).
Depression-dejection symptoms
One meta-analysis was performed and demonstrated a
significant improvement in the depression-dejection sub
scale of the Profile of Mood States Scale (POMS) by a
reduction of 7.68 points for participants in the aerobic
exercise intervention group compared with the non-
exercising control group (Table 7). This represents a
clinically important improvement in depression-
dejection among exercisers compared to non-exercisers.
Adverse events (Safety)
Safety in the form of monitoring adverse events was re-
ported in 12 of the 24 studies (38 %) [25, 27, 29, 31–33,
40, 42, 47–49, 51] (Table 2). Meta-analysis was not pos-
sible due to the scarcity and variability of reporting ad-
verse events. Adverse events were reported in five of the
24 studies, none of which were attributed to exercise or
considered serious [31, 33, 47, 48, 51]. Rigsby [47] re-
ported one death during the study in the counselling
group; however, the death was not attributed to the exer-
cise intervention. Perna [48] reported one hospitalization
during the course of the study [48]. Dolan [51] reported
that one participant in the exercise group had an exacer-
bation of asthma and one participant in the non-
exercising group experienced chest pain at baseline .
Balasubramanyam [33] indicated that adverse events
(such as headaches, dizziness, flushing, diarrhea, nausea
and vomiting and fatigue) were infrequent and events
appeared to be similar across the comparison groups.
Fitch [31] reported two participants in the exercise
group experienced muscle strains related to the resist-
ance training requiring modification of weights. Other-
wise, no serious adverse events were reported and the
exercise program was well tolerated.
Three studies reported no serious adverse events,
health problems, or complications [25, 27, 32]. Two
studies reported that no participants withdrew due to ill-
ness or infection [40, 49]. Grinspoon [42] reported hav-
ing no reported deaths, adverse events or side effects
during the course of the study. Maharaj [29] reported
that none of the participants showed any adverse effects
on their clinical status of CD4 counts, viral load, or in-
crease in opportunistic infections, heart, respiratory and
blood pressure either during or after the exercise inter-
vention. The other studies did not report on any out-
comes of adverse events (Table 2).
Discussion
Ten additional studies were incorporated into this sys-
tematic review, eight of which were able to be included
in meta-analyses [26–33]. This enabled us to perform 28
new meta-analyses for outcomes of CD4 count,
VO2max, maximum heart rate, strength (chest press, leg
press, knee extension and knee flexion, upper and lower
muscle groups), weight, body mass index, percent body
fat, lean body mass, waist circumference, hip circumfer-
ence, waist-to-hip ratio, and quality of life. We were also
able to incorporate additional studies into 16 meta-
analyses from the previous review.
Meta-analyses suggest that performing constant or
interval aerobic exercise, or a combination of constant
aerobic and PRE for at least 20 min three times per week
for at least five weeks appears to be safe and may lead to
improvements in selected outcomes of cardiorespiratory
fitness (maximum oxygen consumption, exercise time),
body composition (lean body mass, leg muscle area, per-
cent body fat), strength (chest press, knee flexors), and
psychological status (quality of life, depression-dejection
symptoms). We also found a trend towards potential
clinically important improvements in cardiorespiratory
fitness and psychological status. Results of this review
suggest that aerobic exercise appears to be safe for
adults living with HIV who are medically stable. This
finding is based on the absence of reports of adverse
events among exercisers within individual studies and
the stability of CD4 count and viral load. Findings should
be interpreted cautiously because results are based on par-
ticipants who completed the exercise interventions and
for whom there were adequate follow-up data.
Results of meta-analyses showed statistically significant
improvements for outcomes of cardiorespiratory fitness
(maximum oxygen consumption (VO2max); exercise
time), strength (chest press, knee flexors), body compos-
ition (increase in lean body mass, leg muscle area, de-
crease in percent body fat), and psychological status
(quality of life, depression-dejection symptoms).
Cardiorespiratory status results demonstrated poten-
tially clinical important improvements in VO2max
among aerobic exercisers compared with non-exercisers,
combined aerobic and resistive exercisers compared to
non-exercisers, and even greater improvements among
participants doing heavy- versus moderate-intensity
exercise.
This systematic review is the first to include meta-
analyses for strength and quality of life, both of which
demonstrated significant improvements among exercisers
compared with non-exercisers. Strength results demon-
strated potentially clinically important improvements in
chest press and knee flexion, among combined progressive
resistive and aerobic exercisers compared with non-
exercisers. Greater clinically important improvements
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were found among resistive compared with aerobic exer-
cisers suggesting a combination of aerobic and PRE may
be ideal to maximize cardiovascular and strength benefits
of exercise [55].
Weight and body composition results reached statis-
tical significance but not clinical importance for lean
body mass, leg muscle area, and percent body fat. Inter-
pretations of changes in weight and body composition
have shifted since the original review since the wide-
spread use of combination antiretroviral therapy. In-
creases in body weight and lean body mass, and
reductions in body fat may be interpreted as favorable
outcomes as a reflection of increase in muscle mass and
strength for adults living with HIV. Future updates of
this review may be able to conduct sub-group analyses for
studies conducted in the pre versus post-combination
antiretroviral era.
Psychological status results demonstrated significant
and clinically important improvements in quality of life
and depression symptoms among exercisers compared
to non-exercisers. Results demonstrated significant im-
provements for six of the eight SF-36 sub-scale scores,
three of which demonstrated potential clinically import-
ant improvements for physical function, role emotional,
and mental health. A significant decrease in pain sub-
scale score on the SF-36 questionnaire for exercisers ver-
sus non-exercisers raised the query of whether exercisers
may have experienced pain with exercise. This requires
further study. Overall, with minimal adverse effects and
few attributed to the interventions, exercise appears to
be safe for adults living with HIV.
No significant differences were found in all but one
meta-analysis for CD4 count or viral load outcomes,
suggesting that aerobic exercise has little impact on im-
munological or virological status. These results were
similar to those in previous versions of this review [10].
Results of this systematic review should be interpreted
cautiously for a variety of reasons. Meta-analyses were
limited due to variation in outcome measures used,
comparison groups and types of interventions, enabling
only two studies to be combined in the majority of
meta-analyses [56]. Studies included in this review dem-
onstrated a high risk of performance bias due to the in-
ability to blind participants to the exercise intervention.
This subsequently resulted in low GRADE ratings for
quality of evidence (Additional file 2). The inability to
blind participants to the aerobic exercise intervention
may have resulted in a Hawthorne effect, whereby par-
ticipants might perceive greater benefits associated with
exercise based on the expectation that exercise should
be linked to positive outcomes. In addition, the lack of
assessor blinding may have resulted in assessor bias
whereby assessors may have measured outcomes in favor
of the exercise intervention. High risk of attrition bias
was also evident due to incomplete data as many studies
had withdrawal rates >15 %. Individual studies in this re-
view included small sample sizes and high withdrawal or
non-adherence rates (0–76 %). Participants who with-
drew from the exercise program were often excluded
from the results by the authors, resulting in a per proto-
col approach to the analysis. Thus, the overall findings
among those who continued to exercise might not re-
flect the general experience of exercise among adults liv-
ing with HIV. Nevertheless, authors often reported
withdrawal rates were similar across comparison groups,
and characteristics of participants who withdrew were
similar to those who remained in the study, minimizing
the potential for migration bias.
The majority of study participants were men between
the ages of 18–65 years. This limits the external validity
and ability to generalize results to women and older
adults living with HIV and comorbidity. Furthermore,
the maximum duration of aerobic exercise intervention
was 52 weeks. Thus the long-term sustainable effects of
aerobic exercise remain less clear. Next, despite combin-
ation antiretroviral therapy now increasingly reaching
developing countries, this review only includes one study
that assessed the impact of aerobic exercise in the devel-
oping country context [45, 46]. More recently, Ezema
[57] similarly reported improvements in VO2max and
CD4 count among aerobic exercisers compared with
non-exercisers living with HIV in Nigeria. Recent evi-
dence from South Africa also includes an investigation
of the impact of home-based and pedometer walking in-
terventions to improve physical activity among adults
living with HIV [58, 59], demonstrating evidence on the
role of exercise and physical activity for adults living
with HIV in developing countries. Finally, recent evidence
has also described the potential benefits of physical activ-
ity and exercise on mental health, neurocognitive out-
comes, and activities of daily living for adults living with
HIV [60–62].
Results of this systematic review are consistent with
findings from previous iterations of this review conclud-
ing exercise is safe and beneficial for people living with
HIV [10, 11]. Results are consistent with a systematic re-
view that assessed the effect of combined twice weekly
aerobic and resistive exercise on cardiorespiratory status,
quality of life, physiologic and functional outcomes for
adults living with HIV and similarly concluded that exer-
cise is safe and beneficial for medically stable adults liv-
ing with HIV [63, 64]. Gomes-Neto and colleagues
concluded that aerobic exercise demonstrated benefits
to cardiorespiratory status and quality of life, specifically
improving body composition and aerobic capacity.
Meta-analyses were not performed as part of this review;
hence findings from our systematic review provide add-
itional details on the pooled effect of aerobic exercise for
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adults living with HIV. Fillipas [65] conducted a system-
atic review and meta-analysis to investigate the effect of
aerobic and resistive exercise on metabolic and body
composition outcomes, including randomized controlled
trials involving at least twice weekly exercise [65]. Re-
sults indicated that exercise resulted in decreased body
mass index, triceps skinfold thickness, body fat percent-
age, waist circumference and waist-to-hip ratio [65]. We
did not perform meta-analyses on metabolic outcomes
as this was beyond the scope of this review; however the
impact of exercise on metabolic health is increasingly
important to consider in the era of combination anti-
retroviral therapy.
Implications for research
Evidence about the safety and effectiveness of aerobic
exercise for adults living with HIV is increasing, includ-
ing narrative and systematic reviews, and clinical guide-
lines that support aerobic exercise interventions in the
context of HIV [63–71]. Recent evidence-informed
guidelines also highlight the potential benefits and role
of aerobic and resistive exercise for older adults living
with HIV [55, 72, 73].
Interpretations of weight and body composition out-
comes should be considered relative to the publication
dates of the included studies. Prior to the advent of com-
bination antiretroviral therapy, studies on exercise
tended to include participants with AIDS-wasting,
whereas recent evidence includes participants on com-
bination antiretroviral therapy with lipodystrophy, body
fat redistribution, or hyperinsulinemia. These studies
commonly assessed the impact of exercise on weight,
body composition, and metabolic outcomes, and reflect
our inclusion of weight and body composition in this re-
view. Furthermore, an increasing number of studies in-
clude interventions with a combination of resistive and
aerobic exercise, which led us to consider the effectiveness
of combined PRE and aerobic exercise with non-exercise.
We observed an increase in the number of studies that
assessed interventions such as tai chi [74, 75] or co-
interventions with exercise such as diet and/or nutritional
counselling [28, 33, 34, 52] metformin [31, 44] and pioglit-
azone [25]. Finally, this review included only 22 % of
women participants reflecting a largely under-represented
population in the HIV and exercise literature.
Future studies should make efforts to include all par-
ticipants in an “intent-to-treat” analysis, blind assessor of
outcomes, and include clinically meaningful and stan-
dardized outcomes to strengthen existing meta-analyses.
As the population living with HIV ages, future research
should include older adults and those living with mul-
tiple concurrent health conditions such as cardiovascular
disease, liver disease, kidney disease, and bone and joint
disorders. As the HIV and exercise literature expands,
future updates of this review should assess the impact of
exercise co-interventions, the impact of exercise on out-
comes including functional status and metabolic or in-
flammatory markers and make an attempt to conduct
sub-group analyses to acknowledge the changing health-
related consequences associated with the pre versus
post-combination antiretroviral era. Finally, given the
majority of studies (18/24) included exercise interven-
tions in clinical settings supervised by health care or re-
search personnel, future research may consider evaluating
the effect of non-supervised exercise interventions or
community-based fitness programmes that may reflect a
self-management model of community-based exercise for
people with HIV [76].
Conclusions
Performing constant or interval aerobic exercise, or a
combination of constant aerobic exercise and progres-
sive resistive exercise three times per week for at least
five weeks appears to be safe and can lead to significant
improvements in outcomes of cardiorespiratory fitness
(maximum oxygen consumption, exercise time), strength
(chest press, knee flexors), body composition (lean body
mass, percent body fat, leg muscle area), and psycho-
logical status (quality of life, depression-dejection symp-
toms). Greater increases in strength were found with
resistive exercise compared with aerobic exercise. Inter-
pretations of weight and body composition outcomes
should be considered relative to the pre versus post
combination antiretroviral therapy era. These findings
are limited to participants who continued to exercise
and for whom there were adequate follow-up data. Aer-
obic exercise is safe and beneficial for adults living with
HIV who are medically stable.
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